🕒 Last update: loading…

Stock GSK plc GSK

GSK plc — Investlytic score 1/5 on the five criteria.

-
-
20/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 1/5 criteria met.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ✅ P/E passed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 22.98%

Price change 2019 → 2020: -21.69%

Price change 2020 → 2021: 19.84%

Price change 2021 → 2022: -20.32%

Price change 2022 → 2023: 5.46%

Price change 2023 → 2024: -8.74%

Price change 2024 → 2025: 45.00%

Price change 2025 → 2026: -3.70%

Price change 2026 (year to date): -4.85%

Financial growth

Revenue CAGR (8 years): 0.83%

Earnings CAGR (8 years): 6.73%

Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.

Debt

Debt-to-equity ratio: 1.08

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 10.16

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 20.20% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
GSK plc11.01.08+0.9 %🔒
Sanofi8.80.28+2.5 %–
EssilorLuxottica S.A.33.60.37+14.2 %–
Moderna, Inc.–0.22+37.8 %–
Pfizer Inc.9.80.78−0.5 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

07

Similar stocks